Cystic fibrosis breathing study pulled before it started
NCT ID NCT03655249
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to test whether a specific breathing technique called autogenic drainage helps clear mucus and improve lung function in people with cystic fibrosis. The study was withdrawn before enrolling any participants, so no results are available. It would have measured changes in lung ventilation using a test called lung clearance index.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autogenic drainage (a breathing technique)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cliniques universitaires Saint-Luc
Brussels, 1200, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A smartphone tool may help cystic fibrosis patients survive the lung transplant waitlist
- Can a smartphone app reveal how CF treatments really work at home?
- Can a peer coach help young people take control of their chronic illness?
- Could a single antibiotic be enough for cystic fibrosis lung infections?
- Early use of powerful CF drugs may boost growth in young children
- Hands-On therapy may soothe cystic fibrosis pain without drugs